Best pediatric cardiac surgeons: TOP 106 doctors

Dr. Yermagambet Mukhanovich is a Cardiologist and Head of the Department of Cardiac Surgery with 15 years experience and a member of the European Association of Cardiothoracic Surgeons. He specializes in open heart surgeries, minimally invasive interventions, and has authored numerous scientific articles on cardiac surgery.

Dr. Murat Saygi is a pediatric cardiologist. He graduated from Cukurova University School of Medicine in 2002. He completed his pediatrics residency at Dokuz Eylul University in 2008. In 2015, he specialized in pediatric cardiology at Istanbul Mehmet Akif Ersoy Thoracic Cardiovascular Surgery Hospital.

Dr. Saygi has worked at several leading hospitals. These include the Ministry of Health Şanlıurfa Pediatric Hospital, Gaziosmanpaşa Taksim Education and Research Hospital, Acıbadem Mehmet Ali Aydınlar University, and Medicana International Hospital in Istanbul. He is known for his expertise in pediatric cardiology. Dr. Saygi is respected for his clinical skills and commitment to pediatric heart care.

Dr. Seyit Ali Kizilkaya is an experienced aesthetic and plastic surgeon. He graduated from Izmir Dokuz Eylul University. He completed his specialization in plastic reconstructive surgery at DEUTF. He received advanced burn training at Ankara GATA Burn Centre and laser treatment training at Numune Research Hospital.

Dr. Kizilkaya has led plastic surgery departments at major hospitals, including Tinaztepe and Su Hospital. He also served as a reconstructive surgeon during his military service. He established a 24-bed clinic, with 12 beds dedicated to burn victims. He managed a team that performed 80 to 100 procedures each week.

He holds an advanced qualification in health law from Izmir University and Ege University. Dr. Kizilkaya speaks English, German, basic Russian, and Turkish.

Head of the Pediatric Heart Transplantation Department, Heart Surgeon

Cardiac Surgeon, Specialist in congenital heart disease treatment

Dr. Blanco is an experienced pediatric cardiac surgeon specializing in cardiovascular surgery with extensive academic and professional experience, including positions as Head of the UCC and Head of the Pediatric Cardiac Surgery Services at various hospitals.

• Specializes in complex congenital heart defects and pediatric heart surgery.
• Expert in treatments like arterial switch and congenital valve repair.
• Trained in Germany, Switzerland, renowned for Pediatric Cardiac Surgery.
• Holds MD from University of Berlin, Ph.D. in cardiology from University of Zurich.
• Accredited by Christian-Albrechts University for medical practice.
• President of the German Society of Pediatric Cardiology.
• Member of European Society of Cardiology, expertise in Pediatric Cardiology.
• Provides online consultations for Pediatric Cardiac Surgery cases.

Kürşat Fidancı is a medical doctor who graduated from GATA Faculty of Medicine in 1999. Between 2000 and 2002, he served as the Chief Physician of the Şırnak Çakırsöğüt Commando Brigade. He completed his residency in Pediatrics from 2002 to 2006 at Istanbul GATA Haydarpaşa Training and Research Hospital. He worked as a Pediatrician at Ankara Beytepe Military Hospital between 2006 and 2009. He completed his subspecialty training in Paediatric Cardiology at GATA Faculty of Medicine Pediatric Cardiology Department from 2010 to 2013. He became an Assistant Professor in 2014 and obtained the title of Associate Professor in April 2016. He worked as a faculty member in the Department of Pediatric Cardiology at GATA Faculty of Medicine between September 2014 and December 2021. As a pediatric cardiologist, Dr. Kürşat Fidancı has seen numerous patients and his medical interests include Fetal Echocardiography, Congenital Heart Diseases, Rheumatic Heart Diseases, Rhythm Disorders, and Athlete's Heart Health and Follow-up.

Academic Education:

• Graduated in Medicine from the University of Barcelona (1999-2005).
• Subspecialist Master’s degree in Pediatric Cardiology at St. Joan de Déu Hospital (2010-2012).
• Medical specialist in Pediatrics and its specific areas at the Albacete University Hospital Complex (2006-2010).
• Studying the PhD of Pediatrics at the University of Barcelona Autonomous (2019-present).

Professional Experience:

• Pediatric Cardiologist at the HM Nens Hospital in Barcelona (2012-2018).
• Head of Service of the Cardiology Department at the HM Nens Hospital in Barcelona (2018-present).

Scientific and Teaching Activity:

• Member of the Association for European Pediatric and Congenital Cardiology (AEPC), the Spanish Society of Pediatric Cardiology and Congenital Heart Disease (SECPCC), the Spanish Society of Pediatrics (SEP) and the Catalan Society of Pediatrics (SCP).

Areas of Professional Interest:

• Area of excellence: Preventive Cardiology in cardiovascular diseases.
• Research lines: Cardiovascular risk in adolescents with pathology or a family history of cardiovascular disease. Role of the microbiota as a regulatory factor in obesity and metabolic disease.
• Doctoral Thesis: Evaluation of early changes in the myocardium and cardiovascular system of adolescents with severe obesity.
• Kawasaki Disease: Member of the Asenkawa Medical Advisory Team (Association of Parents of Kawasaki Disease).

Dr. Francisco Javier Parra Jimenez collaborated with the Cardiology Service of the General University Hospital of Guadalajara from January to November 1999. He started working in the HM Hospital group in January 1999 with Dr. D. Manuel de Artaza until 2007, when he was appointed Head of the Cardiology Service at the HM Sanchinarro University Hospital.

At the present time he holds the position of Head of the Clinical Cardiology Service of HMCIEC (Comprehensive Center for Cardiovascular Diseases) of HM Hospital, where he carries out his work as a doctor and maintains his Clinical Cardiology practice at the HM Montepríncipe, Sanchinarro and Madrid Centers.

Dr. Francisco Javier Parra Jimenez also coordinates the activity of more than 30 clinical cardiologists and about 20 people dedicated to nursing activities.

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21